ARQT - Arcutis Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ARQT is currently covered by 7 analysts with an average price target of $37.14. This is a potential upside of $10.78 (40.9%) from yesterday's end of day stock price of $26.36.

Arcutis Biotherapeutics's activity chart (see below) currently has 159 price targets and 147 ratings on display. The stock rating distribution of ARQT is 93.33% BUY and 6.67% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 47.79% of the time, taking 128.29 days on average.

Highest price target for ARQT is $44, Lowest price target is $33, average price target is $37.14.

Most recent stock forecast was given by TYLER VAN BUREN from TD COWEN on 05-Nov-2026. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Aug-2025

$40

$13.64 (51.75%)

$35

17 days ago
(05-Nov-2026)

2/4 (50%)

$13 (48.15%)

55

Buy Since 25-Feb-2020

$44

$17.64 (66.92%)

$38

1 months 3 days ago
(19-Oct-2026)

1/4 (25%)

$12.11 (37.97%)

27

Buy Since 07-Sep-2022

$40

$13.64 (51.75%)

$36

3 months 16 days ago
(06-Aug-2026)

19/25 (76%)

$13.57 (51.34%)

451

Buy Since 03-Jul-2025

$34

$7.64 (28.98%)

$32

6 months 15 days ago
(07-May-2026)

4/4 (100%)

$13.34 (64.57%)

171

Buy Since 09-Feb-2024

$35

$8.64 (32.78%)

$37

8 months 20 days ago
(02-Mar-2026)

14/41 (34.15%)

$10.24 (41.36%)

258

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARQT (Arcutis Biotherapeutics) average time for price targets to be met?

On average it took 128 days for the stock forecasts to be reached, with an average price target met ratio of 47.79%.

Which analyst most recently updated their price target on ARQT (Arcutis Biotherapeutics)?

Tyler Van Buren

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics)?

Tyler Van Buren works at TD COWEN and has 14 price targets and 10 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics)?

Graig Suvannavejh with the highest potential upside of $28.64

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics)?

Chris Shibutani with the lowest potential downside of -$11.36
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?